PancAlert feasibility study is designed to validate compelling results from a discovery phase completed earlier this year in partnership with Liquid Biosciences
Read MoreGuido Baechler
Mainz Biomed Targets Cancer Prevention with mRNA-Powered eAArly DETECT 2 Study
Mainz Biomed innovative CRC screening approach combines five proprietary mRNA biomarkers with advanced AI and diagnostic tools.
Read More